Global Medical AI Industry Atlas: Covering 200+ Companies and Over $10 Billion in Total Funding

According to data compiled by China Business Industry Research Institute, the market size of artificial intelligence in China reached RMB 9.661 billion in 2016, with a growth rate of 37.9%. The market has been expanding continuously, is projected to exceed RMB 13 billion in 2017 (a 40.7% increase), and is expected to reach RMB 20 billion in 2018. Industry experts believe that, compared with fields such as speech recognition applications and autonomous driving, the “major boom” trend of artificial intelligence is foreseeable.Artificial Intelligence Has Broad Prospects in the Healthcare Sector。

Founder Securities' research report points out that,Healthcare Has Strong Potential Demand for Artificial Intelligence. Artificial intelligence will bring disruptive transformation to the healthcare sector, and in the long run, it is expected to help address, from a technological perspective, issues such as the unequal distribution of medical resources, weak primary healthcare services, high medical costs, and significant pressure on health insurance cost containment in China.

Strong policy support in China has also provided fertile ground for “AI + Healthcare.” According to data compiled by VCBeat, since 1992, more than 200 local-level policies and over 80 national-level policies have been issued. In 2016 alone, more than 100 AI-related policies were released.Policy Quantitative Changes Will Drive Qualitative Leaps in Artificial Intelligence。

Last October, Baidu Medical Brain was launched in Beijing, marking the latest achievement of Baidu’s artificial intelligence initiatives in the healthcare sector. In March this year, Zhejiang University announced the establishment of the Ruiyi Artificial Intelligence Research Center, supported by a RMB 100 million donation from the internet healthcare platform WeDoctor Group. Recently, Yitu, a company engaged in innovative AI research, completed its C-round financing of RMB 380 million, led by Hillhouse Capital Group, with participation from Yunfeng Capital, Sequoia Capital, Gaorong Capital, and ZhenFund.

Currently, a relatively complete industrial structure for global “AI + Healthcare,” encompassing the foundation, technology, and application layers, has taken shape. Large corporations are progressively strengthening their presence in the foundation and technology layers, which feature high technical barriers, while startups are clustering in the application layer, creating a vibrant and flourishing landscape.

To this end, VCBeat's VBInsight hasAI + HealthcareA panoramic scan of the industry was conducted, and we have sorted out the domestic landscape since 1992300+ Relevant Policies，Over 200 Domestic and International AI + Healthcare Companies，Over 800 Investment and Financing Deals Totaling More Than RMB 10 Billion, outlining the most comprehensive AI + healthcareIndustry Landscape, helping industry professionals quickly grasp the current macro landscape and development trends of the sector, assisting entrepreneurs in identifying new avenues for exploration, and enabling investors to uncover undervalued opportunities.

This is a data atlas offering a panoramic view of the industry, as well as an inspiring report that sparks thought and creativity. 《AI + Healthcare Data Report》willPolicies, Development, Landscape, Layout, InvestmentFive Key Dimensions to Uncover Trends Behind the Data.Data Series ReportThis is also our newly launched membership knowledge service. Each week, we curate the latest, most comprehensive, and timely data around a core theme, primarily using charts and graphs to help you quickly and clearly grasp industry trends.

All data in this report are sourced from the VCBeat database. VCBeat members can log inVCBeat Mini Program/Official WebsiteView the full report and useDatabaseQuery relevant company information.

Not yet a VCBeat member? Scan the QR code below.

(Purchase the VCBeat Membership Beta now for only: RMB 365/year)

Among the more than 100 relevant policies released in the past year, what benefits does the latest policy bring to the industry?

Besides medical imaging diagnosis, hospital management, and health management, what are the other seven major application areas of artificial intelligence in the healthcare sector?

What Does the Most Comprehensive Industry Landscape, Covering Over 60 Domestic Companies and More Than 180 Overseas Companies, Reveal About the Industry Ecosystem?

Beyond Baidu Brain, do you know the three niche sectors targeted by Baidu’s more than 200 patents, and what are its ambitions?

What are the respective strategic approaches adopted by BAT and other major companies? What are their respective strategic priorities?

The average funding amount for new drug discovery abroad reaches as high as $21.8 million. What other overseas investment hotspots remain largely untapped in China?

What Are the Top 5 Companies with the Highest Cumulative Financing in China and Abroad Doing?

These questions can all be addressed in “AI + Healthcare Data Report》, which demonstrates the power of data and underscores the value and significance of our data-driven report series. Below are excerpts from the reports.

60+China180+Overseas Companies Map Out the Industry Development Landscape

The application of artificial intelligence in the healthcare sector is flourishing, encompassing more than ten categories such as medical record/literature information analysis, virtual assistants, patient risk prediction, and hospital management. These industry applications illustrate AI use cases across various stages, including cognition, prediction, decision-making, and integrated solutions. VCBeat has mapped out a comprehensive landscape of industry development, drawing on data from over 60 domestic companies and more than 180 overseas AI-plus-healthcare companies.

(Members can query the company-related information involved in the industry map through the newly added Industry Map section of the VCBeat Knowledge Base)

Baidu200+Tencent Leads the Market with Patents3TimeInvestment: Seizing Strategic Positions

Baidu’s number of AI-related patents far exceeds those of Tencent and Alibaba. Data from 2015–2016 show that its patent volume doubled, reflecting Baidu’s strong demand for AI patents amid broad market prospects.

Tencent AI has few self-developed projects in the medical field, with external investment serving as its primary strategic approach. Through investments in iCarbonX, CloudMedx, and Sipei Network, Tencent has established a presence in health management, hospital management, and oncology.

Policies Issued Since 2010205Article: Policy volume growth in 2016 increased by nearly3times

Since 1992, more than 200 local policies and over 80 national-level policies have been issued. In 2015, 34 policies were released, and by 2016, the number of AI-related policies surged to 100. This quantitative shift in policy will drive a qualitative transformation in artificial intelligence.

National AI Policies in China

AI + Healthcare Policy

Domestic Projects"Go All Out to Boost Development Momentum"Cumulative FinancingNear2 billion

With a total financing volume exceeding RMB 10 billion, the market economy has significantly boosted morale for AI+ healthcare startups. Among the nearly RMB 2 billion in cumulative financing secured by domestic projects, iCarbonX stands out most prominently, having raised over RMB 1 billion. Other key funded projects are primarily focused on the field of medical image recognition.

Top 5 Domestic Projects by Cumulative Investment

(The above is an excerpt from this report)

Scan the QR code below to become an official VCBeat member and access the full version.《AI + Healthcare Data Report》Moreover, over the coming year, you will have unlimited access to comprehensive industry trend reports, stay abreast of the latest global investment and financing developments, leverage a complete database of healthcare companies, and tap into extensive resource-matching opportunities. You may also click “Read Full Article” at the bottom left of this page to purchase and read the report. Entrepreneurs, investors, and industry professionals are welcome to contact us for communication and discussion.

(Scan the QR code to purchase a membership)